ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,593,305 | +0.4% | 9,104,275 | +3.5% | 10.83% | -7.5% |
Q2 2023 | $32,447,354 | +27.9% | 8,793,321 | +14.8% | 11.70% | +37.6% |
Q1 2023 | $25,360,194 | -5.8% | 7,661,690 | +10.4% | 8.50% | -24.9% |
Q4 2022 | $26,927,200 | +121.6% | 6,940,000 | +38.8% | 11.33% | +107.4% |
Q3 2022 | $12,150,000 | -12.3% | 5,000,000 | -28.6% | 5.46% | -15.3% |
Q2 2022 | $13,860,000 | +6.2% | 7,000,000 | -1.8% | 6.45% | +19.1% |
Q1 2022 | $13,051,000 | -6.6% | 7,131,808 | -28.0% | 5.41% | -15.6% |
Q4 2021 | $13,975,000 | +272.6% | 9,911,577 | +1091.7% | 6.41% | +181.4% |
Q2 2018 | $3,751,000 | +1628.6% | 831,731 | +1129.5% | 2.28% | +1653.1% |
Q4 2017 | $217,000 | – | 67,647 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |